ARTICLE | Company News

J&J, The Carlyle Group deal

January 20, 2014 8:00 AM UTC

Johnson & Johnson received a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical Diagnostics business for $4.2 billion. The business markets products to screen for, diagnose and monitor diseases for the transfusion community, with a focus on hospitals, laboratories and blood centers. J&J has until March 31 to accept the offer. The deal is expected to close around mid-year if the pharma accepts the offer. Barclays and Goldman Sachs are advising Carlyle. Latham & Watkins LLP is its legal advisor. ...